Clinical Trials Logo

Alveolar Echinococcosis clinical trials

View clinical trials related to Alveolar Echinococcosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02876146 Completed - Clinical trials for Alveolar Echinococcosis

Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole

EchinoVISTA
Start date: June 2012
Phase: N/A
Study type: Interventional

Study design to define improved management of patients with hepatic alveolar echinococcosis treated with albendazole and especially make appropriate and timely decision of treatment withdrawal . Based on exploratory analysis of existing and newly developed biological and imaging exams, for diagnosis and follow-up, and study of the relationship of these markers to the viability of the parasite and/or the activity of the parasitic lesions The study included two series of patients: operated on (curative hepatectomy) // non-operated on

NCT ID: NCT02509884 Completed - Clinical trials for Alveolar Echinococcosis

Long-term Results of Comprehensive AE Management

Start date: January 1992
Phase: N/A
Study type: Observational

Comprehensive diagnosis and treatment of Alveolar Echinococcosis : A single-center, long-term observational study of 312 Patients in Germany. Human alveolar echinococcosis (AE) is the most Iethal human helminthic infection and is one of the 17 neglected tropical diseases prioritized by the World Health Organization (WHO). Its incidence is low in endemic regions of Central and Western Europe (0.03-0.05/100,000), but morbidity and treatment costs are high. In this observational study, the investigators assessed the severity of the disease using the PNM staging system and report on the long-term results of specific AE therapy in an interdisciplinary team of clinicians.

NCT ID: NCT00658294 Completed - Clinical trials for Alveolar Echinococcosis

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

Start date: January 2008
Phase: N/A
Study type: Observational

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles - Trial with medicinal product